PROVERA Side Effects

7013154-8 | Colon Cancer, Nosocomial Infection, Weight Increased
on Sep 16, 2010 Female patient from UNITED STATES , weighting 130.1 lb, was diagnosed with hot flush and was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer, nosocomial infection, weight increased. Provera dosage: 2.5 Mg, Daily. During the same period patient was treated with PREMARIN (0.625 Mg, Daily) (View Premarin Review and Premarin Label ). Patient was hospitalized.

6984381-0 | Breast Cancer
Patient was taking Provera (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Apr 19, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Provera dosage: . During the same period patient was treated with ESTROPIPATE (View Estropipate Review and Estropipate Label ).

6972894-7 | Breast Cancer Female
Adverse event was reported on Sep 01, 2010 by a Female patient taking Provera (View Usage) (Dosage: 10 Mg, Unk) was diagnosed with hypertension, depression (What is depression?) and. Location: UNITED STATES , weighting 178.6 lb, After Provera was administered, patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), ESTRACE (Unk) (View Estrace Review and Estrace Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), PRINZIDE (Unk) (View Prinzide Review and Prinzide Label ), ZOLOFT (100 Mg, Unk) (View Zoloft Review and Zoloft Label ).

6972888-1 | Abnormal Behaviour, Feeling Abnormal, Libido Decreased, Mania
on Aug 30, 2010 Female patient from UNITED STATES , 53 years of age, weighting 145.5 lb, was diagnosed with hot flush and was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, feeling abnormal, libido decreased, mania. Provera dosage: Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Daily) (View Premarin Review and Premarin Label ), VITAMINS (View Vitamins Review and Vitamins Label ).


6972751-6 | Abortion Spontaneous
on Aug 30, 2010 Female patient from NEW ZEALAND , 35 years of age, weighting 143.3 lb, was diagnosed with amenorrhoea and was treated with Provera (View Usage). Patient had the following side effects: abortion spontaneous. Provera dosage: 5 Mg, 2x/day.

6962899-4 | Hyperhidrosis
Patient was taking Provera (View Usage). After Provera was administered, patient had the following side effects: hyperhidrosis on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with off label use, lung disorder, hypertension, renal disorder, pain (What is pain?), total lung capacity decreased and. Provera dosage: 10 Mg, 6x/daily. During the same period patient was treated with COZAAR (25 Mg, Daily) (View Cozaar Review and Cozaar Label ), ATENOLOL (75 Mg, Daily) (View Atenolol Review and Atenolol Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), PROCRIT (6000 Iu, Weekly) (View Procrit Review and Procrit Label ), FENTANYL (25 Ug, Unk) (View Fentanyl Review and Fentanyl Label ), OXYGEN (Unk) (View Oxygen Review and Oxygen Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ).

6943361-1 | Breast Cancer Female
Adverse event was reported on Aug 18, 2010 by a Female patient taking Provera (View Usage) (Dosage: 10 Mg, Unk) . Location: UNITED STATES , weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: breast cancer female. During the same period patient was treated with OGEN (Unk) (View Ogen Review and Ogen Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), ESTRADERM (Unk) (View Estraderm Review and Estraderm Label ), CYCRIN (2.5 Mg, Unk) (View Cycrin Review and Cycrin Label ), CLIMARA (Unk) (View Climara Review and Climara Label ), ESTROGEN NOS (Unk) (View Estrogen Nos Review and Estrogen Nos Label ).

6943186-7 | Breast Cancer Female
on Aug 17, 2010 Female patient from UNITED STATES , weighting 145.5 lb, was treated with Provera (View Usage). Patient had the following side effects: breast cancer female. Provera dosage: 10 Mg, Unk. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (10 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ESTRATEST (Unk) (View Estratest Review and Estratest Label ), PREMPRO (0.625) (View Prempro Review and Prempro Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ).

6943156-9 | Breast Cancer Female
on Aug 17, 2010 Female patient from UNITED STATES , weighting 159.8 lb, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: 2.5 Mg, Unk. During the same period patient was treated with OGEN (Unk) (View Ogen Review and Ogen Label ), MEDROXYPROGESTERONE ACETATE (Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (1.25 Mg, Unk) (View Premarin Review and Premarin Label ), ORTHO EST (Unk) (View Ortho-est Review and Ortho-est Label ), ESTROPIPATE (Unk) (View Estropipate Review and Estropipate Label ), ESTROGEN NOS (Unk) (View Estrogen Nos Review and Estrogen Nos Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ).

6936495-9 | Breast Cancer Female
Patient was taking Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 269.0 lb, . Provera dosage: 2.5 Mg, Unk. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (2.5 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (View Premarin Review and Premarin Label ), ESTRADERM (0.1 Mg, Unk) (View Estraderm Review and Estraderm Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), ESTROGENS (Unk) (View Estrogens Review and Estrogens Label ).

6936222-5 | Breast Cancer Female
Adverse event was reported on Aug 13, 2010 by a Female patient taking Provera (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 143.3 lb, Patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (Unk) (View Premarin Review and Premarin Label ), PREMPHASE 14/14 (Unk) (View Premphase 14/14 Review and Premphase 14/14 Label ), PREFEST (Unk) (View Prefest Review and Prefest Label ).

6936175-X | Breast Cancer Female
on Aug 17, 2010 Female patient from UNITED STATES , weighting 176.4 lb, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: Unk. During the same period patient was treated with OGEN (Unk) (View Ogen Review and Ogen Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTROGENS (View Estrogens Review and Estrogens Label ), ESTRATAB (Unk) (View Estratab Review and Estratab Label ).

6933950-2 | Breast Cancer Female
on Aug 13, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Provera dosage: 2.5 Mg, Unk. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (2.5 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), CYCRIN (2.5 Mg, Unk) (View Cycrin Review and Cycrin Label ), PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ).

6923013-4 | Blood Pressure Increased, Dyspnoea, Headache, Rash Pruritic
Patient was taking Provera (View Usage). Patient had the following side effects: blood pressure increased, dyspnoea, headache (What is headache?), rash pruritic on Aug 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, . Provera dosage: 30 Mg, Unk. During the same period patient was treated with BISOPROLOL (5 Mg, Unk) (View Bisoprolol Review and Bisoprolol Label ), GLUCOPHAGE (500 Mg, 2x/day) (View Glucophage Review and Glucophage Label ), INSULIN GLULISINE (Unk) (View Insulin Glulisine Review and Insulin Glulisine Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ), ROSUVASTATIN (10 Mg, Unk) (View Rosuvastatin Review and Rosuvastatin Label ), LEVOCETIRIZINE (Unk) (View Levocetirizine Review and Levocetirizine Label ).

6914419-8 | Breast Cancer Female
Adverse event was reported on Jul 30, 2010 by a Female patient taking Provera (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 145.5 lb, After Provera was administered, patient had the following side effects: breast cancer female. During the same period patient was treated with PREMPRO (Unk) (View Prempro Review and Prempro Label ), CYCRIN (Unk) (View Cycrin Review and Cycrin Label ), ESTRADERM (Unk) (View Estraderm Review and Estraderm Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ).

6886854-8 | Breast Cancer Female
on Jul 26, 2010 Female patient from UNITED STATES , weighting 125.7 lb, was diagnosed with hypertension and was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Provera dosage: Unk. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), LOZOL (2.5 Mg, 1x/day) (View Lozol Review and Lozol Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ).

6876003-4 | Breast Cancer
on Jul 16, 2010 Female patient from UNITED STATES , weighting 123.5 lb, was treated with Provera (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Provera dosage: Unk. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ).

6871357-7 | Breast Cancer Female, Cardiac Fibrillation, Endometrial Cancer, Ovarian Cancer
Patient was taking Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female, cardiac fibrillation, endometrial cancer, ovarian cancer on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 174.2 lb, . Provera dosage: Unk. During the same period patient was treated with ESTRACE (Unk) (View Estrace Review and Estrace Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6871055-X | Breast Cancer Female
Adverse event was reported on Jul 14, 2010 by a Female patient taking Provera (View Usage) (Dosage: Unk) was diagnosed with menopausal symptoms, hypertension and. Location: UNITED STATES , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: breast cancer female. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (Unk) (View Premarin Review and Premarin Label ), DIOVAN (320 Mg, Unk) (View Diovan Review and Diovan Label ).

6871052-4 | Breast Cancer Female
on Jul 16, 2010 Female patient from UNITED STATES , weighting 141.1 lb, was treated with Provera (View Usage). Patient had the following side effects: breast cancer female. Provera dosage: 2.5 Mg, Unk. During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ).

6861490-8 | Embolism Venous, Pulmonary Embolism, Pulmonary Infarction
on Jul 20, 2010 Female patient from UNITED STATES , 43 years of age, weighting 224.2 lb, was diagnosed with dysmenorrhoea, menorrhagia and was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: embolism venous, pulmonary embolism (What is pulmonary embolism?), pulmonary infarction. Provera dosage: . Patient was hospitalized.

6860047-2 | Abortion Spontaneous
Patient was taking Provera (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Jul 13, 2010 from NEW ZEALAND Additional patient health information: Female patient , 35 years of age, was diagnosed with amenorrhoea and. Provera dosage: Unk.

6836222-X | Breast Cancer Female
Adverse event was reported on Aug 17, 2009 by a Female patient taking Provera (View Usage) (Dosage: Mg) . Location: UNITED STATES , 58 years of age, weighting 141.1 lb, Patient had the following side effects: breast cancer female. During the same period patient was treated with PREMPRO (5 Mg) (View Prempro Review and Prempro Label ), EVISTA (View Evista Review and Evista Label ), PREMARIN (5 Mg) (View Premarin Review and Premarin Label ).

6836208-5 | Breast Cancer Female
on Aug 18, 2009 Female patient from UNITED STATES , 56 years of age, weighting 125.7 lb, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: 10 Mg, Oral. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), PREMPRO (0.625/2.5mg) (View Prempro Review and Prempro Label ).

6836205-X | Breast Cancer
on May 21, 2009 Female patient from UNITED STATES , 64 years of age, weighting 174.2 lb, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Provera dosage: 2.5 Mg, Oral. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (2.5 Mg, Oral) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ESTRADIOL (1 Mg) (View Estradiol Review and Estradiol Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ).

6836201-2 | Breast Cancer Female
Patient was taking Provera (View Usage). Patient had the following side effects: breast cancer female on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 119.0 lb, . Provera dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

6836200-0 | Breast Cancer Female
Adverse event was reported on Aug 18, 2009 by a Female patient taking Provera (View Usage) (Dosage: 5 Mg, Oral; 10 Mg Oral) . Location: UNITED STATES , 53 years of age, weighting 180.8 lb, After Provera was administered, patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (0.9 Mg; 1.25 Mg; 2.5 Mg) (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), CYCRIN (10 Mg) (View Cycrin Review and Cycrin Label ), ESTRATEST (1.25 Mg) (View Estratest Review and Estratest Label ).

6836197-3 | Breast Cancer Female
on Aug 18, 2009 Female patient from UNITED STATES , 51 years of age, weighting 165.3 lb, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Provera dosage: 5 Mg, Oral. During the same period patient was treated with PREMARIN (0.625mg/1.25mg) (View Premarin Review and Premarin Label ), ESTRATEST (View Estratest Review and Estratest Label ).

6836195-X | Breast Cancer Female
on Aug 17, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Provera (View Usage). Patient had the following side effects: breast cancer female. Provera dosage: 10 Mg, Oral. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ). Patient was hospitalized.

6836194-8 | Breast Cancer Female
Patient was taking Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Provera dosage: Oral. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ).

6836193-6 | Breast Cancer Female
Adverse event was reported on Sep 28, 2009 by a Female patient taking Provera (View Usage) (Dosage: 2.5 Mg, Oral) . Location: UNITED STATES , 69 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: breast cancer female. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ).

6836179-1 | Breast Cancer Female
on Aug 13, 2009 Female patient from UNITED STATES , 49 years of age, weighting 119.0 lb, was treated with Provera (View Usage). Patient had the following side effects: breast cancer female. Provera dosage: 2.5 Mg, Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6836149-3 | Breast Cancer Female
on Aug 13, 2009 Female patient from UNITED STATES , 74 years of age, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ).

6836135-3 | Breast Cancer Female
Patient was taking Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female on Aug 18, 2009 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 141.1 lb, . Provera dosage: 2.5 Mg, Oral. During the same period patient was treated with PREMARIN (0.625) (View Premarin Review and Premarin Label ).

6836133-X | Breast Cancer Female
Adverse event was reported on Aug 18, 2009 by a Female patient taking Provera (View Usage) (Dosage: Oral) . Location: UNITED STATES , 58 years of age, weighting 138.9 lb, Patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6836131-6 | Breast Cancer Female
on Aug 13, 2009 Female patient from UNITED STATES , 68 years of age, weighting 185.2 lb, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: Oral. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (10 Mg, Oral) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

6836124-9 | Breast Cancer
on May 21, 2009 Female patient from UNITED STATES , 69 years of age, weighting 149.9 lb, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Provera dosage: 10 Mg, Oral. During the same period patient was treated with PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ).

6836111-0 | Breast Cancer
Patient was taking Provera (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, . Provera dosage: 10 Mg, Oral; 2.5 Mg, Oral; 5mg. During the same period patient was treated with OGEN (0.625 Mg) (View Ogen Review and Ogen Label ), PREMARIN (0.9 Mg; 0.625 Mg) (View Premarin Review and Premarin Label ).

6836109-2 | Breast Cancer Female
Adverse event was reported on Aug 17, 2009 by a Female patient taking Provera (View Usage) (Dosage: 2.5 Mg, Oral) . Location: UNITED STATES , 67 years of age, weighting 121.9 lb, After Provera was administered, patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ZOCOR (View Zocor Review and Zocor Label ).

6836085-2 | Breast Cancer Female
on Aug 18, 2009 Female patient from UNITED STATES , 58 years of age, weighting 183.0 lb, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Provera dosage: 10 Mg, Oral; 2.5 Mg, Oral. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ).

6836084-0 | Breast Cancer Female
on Aug 17, 2009 Female patient from UNITED STATES , 51 years of age, weighting 145.5 lb, was treated with Provera (View Usage). Patient had the following side effects: breast cancer female. Provera dosage: 1.25 Mg, Oral. During the same period patient was treated with PREMARIN (1.25 Mg) (View Premarin Review and Premarin Label ).

6836081-5 | Breast Cancer
Patient was taking Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer (What is breast cancer?) on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 129.0 lb, . Provera dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6836063-3 | Breast Cancer
Adverse event was reported on Aug 18, 2009 by a Female patient taking Provera (View Usage) (Dosage: 10 Mg, Oral) . Location: UNITED STATES , 52 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (1.25 Mg; 0.625 Mg) (View Premarin Review and Premarin Label ).

6836062-1 | Breast Cancer
on May 21, 2009 Female patient from UNITED STATES , 50 years of age, was treated with Provera (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Provera dosage: Oral. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (Oral) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMARIN (View Premarin Review and Premarin Label ).

6836057-8 | Breast Cancer Female
on May 21, 2009 Female patient from UNITED STATES , 66 years of age, weighting 119.0 lb, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6835955-9 | Breast Cancer Female
Patient was taking Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 130.1 lb, . Provera dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ).

6835919-5 | Breast Cancer Female
Adverse event was reported on May 21, 2009 by a Female patient taking Provera (View Usage) (Dosage: Oral) . Location: UNITED STATES , 49 years of age, Patient had the following side effects: breast cancer female. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6835917-1 | Breast Cancer Female
on May 21, 2009 Female patient from UNITED STATES , 57 years of age, was treated with Provera (View Usage). After Provera was administered, patient had the following side effects: breast cancer female. Provera dosage: 10 Mg, Oral. During the same period patient was treated with MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTROGENS () (View Estrogens () Review and Estrogens () Label ).

6835916-X | Breast Cancer Female
on May 21, 2009 Female patient from UNITED STATES , 60 years of age, was treated with Provera (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Provera dosage: Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

6835903-1 | Breast Cancer
Patient was taking Provera (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Aug 18, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 119.0 lb, . Provera dosage: Oral. During the same period patient was treated with PREMARIN (0.625 Mg) (View Premarin Review and Premarin Label ), PREMPRO (0.625/2.5mg) (View Prempro Review and Prempro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).